Wegovy pill expands weight loss options in the USJanuary 8, 2026 MENA Newswire, NEW YORK: Novo Nordisk’s blockbuster weight-loss drug Wegovy is now available in an oral pill form in the United States, marking a major…
Novo Nordisk offers Ozempic direct for $499 monthlyAugust 18, 2025 Uninsured Americans can now access Ozempic for $499 monthly as Novo Nordisk rolls out a direct-to-consumer model through telehealth providers.
Novo Nordisk shares fall 20 percent after CEO change and outlook cutJuly 29, 2025 Novo Nordisk shares dropped 20% after cutting full-year guidance and naming a new CEO, citing U.S. market weakness for Wegovy and Ozempic.